Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club
Production & Manufacturing
Fine & Speciality Chemicals
Return to: PBR Home | Production & Manufacturing | Fine & Speciality Chemicals

Fine & Speciality Chemicals

BASF, Dyadic enter into non-exclusive research, license agreement By PBR Staff Writer
BASF and Dyadic International have entered into a non-exclusive worldwide research and license agreement.
Production & Manufacturing > Fine & Speciality Chemicals > News
Cempra, Toyama Chemical sign exclusive license, development agreement for solithromycin By PBR Staff Writer
Cempra, a clinical-stage pharmaceutical company, has signed an exclusive license and development agreement for solithromycin with Toyama Chemical, a subsidiary of Fujifilm Holdings in Japan.
Production & Manufacturing > Fine & Speciality Chemicals > News American Pacific reports increased Q2 net income By PBR Staff Writer
American Pacific Corporation, a manufacturer of fine chemicals and specialty chemicals, has reported a net income of $2.73m, or $0.34 per diluted share, for the second quarter ended 31 March 2013 compared to $1.05m, or $0.16 per diluted share, for the second quarter ended 31 March 2012.
Production & Manufacturing > Fine & Speciality Chemicals > News
See more Fine & Speciality Chemicals news

Latest Fine & Speciality Chemicals News and Insight

View all Fine & Speciality Chemicals news or find news targeted to your interests
American Pacific reports increased Q2 net income
10 May 2013 | By PBR Staff Writer
American Pacific Corporation, a manufacturer of fine chemicals and specialty chemicals, has reported a net income of $2.73m, or $0.34 per diluted share, for the second quarter ended 31 March 2013 compared to $1.05m, or $0.16 per diluted share, for the second quarter ended 31 March 2012.
Production & Manufacturing > Fine & Speciality Chemicals > News
Assessment of the Impact of the European Pharmacopoeia Monograph for Norflurane
09 May 2013 | By Mexichem Fluor
A draft monograph for HFA 134a (norflurane) was first published in the April 2011 edition of PHARMAEUROPA (Volume 23, No.2), with the usual period for comment and review. Mexichem Fluor provided comments on this draft via the appropriate national pharmacopoeia authority, in this case the British Pharmacopoeia. The final monograph was included in Supplement 7.7 (published 1 October 2012) to the 7th Edition of European Pharmacopoeia (Ph Eur). Supplement 7.7 has an implementation date of 1 April 2013.
Production & Manufacturing > Fine & Speciality Chemicals > White Papers
Vertellus upgrades Belgium facility to manufacture niacin for pharmaceutical use
03 May 2013 | By PBR Staff Writer
Vertellus Specialties has upgraded its facility in Antwerp, Belgium, to manufacture niacin (nicotinic acid) for pharmaceutical use.
Production & Manufacturing > Fine & Speciality Chemicals > News
Parchem - fine & specialty chemicals
Parchem is the leading global supplier of specialty raw materials. Our expertise lends itself to servicing the pharmaceutical and specialty chemicals industries. Innovative technology, global sourcing and custodial supply chain management are the core tenets of Parchem's business model. As a leading supplier we are committed to the highest integrity of customer centric services and sourcing of the most difficult to find raw materials in the world.
Production & Manufacturing > Fine & Speciality Chemicals > Suppliers
Suven Life Sciences receives four product patents for NCEs
19 April 2013
Suven Life Sciences, a biopharmaceutical company, has received four product patents for its new chemical entities (NCEs).
Production & Manufacturing > Fine & Speciality Chemicals > News
Alitair to sell two ion-exchange resin patents
12 April 2013 | By PBR Staff Writer
US-based Alitair Pharmaceuticals has retained Finn, Warnke & Gayton to sell two Alitair patents and an associated royalty stream at a sealed bid sale on 24 May 2013.
Production & Manufacturing > Fine & Speciality Chemicals > News
Chemoswed - When Good Enough Isn't
Chemoswed is the reliable Swedish custom synthesis specialist, supplying active ingredients since 1944. With a background in Pharmacia, Chemoswed is since 1996 an independent entity within the DuPont group, offering cost-effective, turn-key solutions to API needs worldwide.We have established unparalleled experience and technology, enabling efficient development and production of quality active pharmaceutical ingredients in quantities from 100 grams to 50 tons.
Production & Manufacturing > Fine & Speciality Chemicals > Suppliers
Ajinomoto completes acquisition of Althea Technologies
05 April 2013 | By PBR Staff Writer
Ajinomoto has completed the acquisition of Althea Technologies, a provider of biopharmaceutical development and manufacturing services.
Production & Manufacturing > Fine & Speciality Chemicals > News
Atlantic Research Chemicals - Your Partner in Building Block Supply
Founded with over 20 combined years of experience within the drug discovery market, Atlantic Research Chemicals aims to offer the most select, diverse and unique products available within the drug discovery business sector.
Production & Manufacturing > Fine & Speciality Chemicals > Suppliers
Production
03 April 2013
Our laboratories offer you cost effective cGMP manufacturing of smaller quantities (gram scale) API's. The kilo lab enables us to conveniently bridge the gap between lab and pilot scale and our chemical production plant is designed for multi-purpose use in small to full scale, ranging from kilo to multi-tons.
Production & Manufacturing > Fine & Speciality Chemicals > Products
View all Fine & Speciality Chemicals news or find news targeted to your interests

Buy the latest industry research online today!
African Pharmaceutical Directory 2013 01 February 2013 API research into pharmaceutical companies and corporations Buy online from $200